La registrazione del dominio è in attesa. Controlla di nuovo tra un'ora

Testimonianze

1 mese fa
Medico molto competente, sensibile e attento all’ascolto del paziente
- Rodolfo V
8 mesi fa
Medico molto competente, attento, empatico e disponibile
- Silvia M
un anno fa
- Federico B

Cardiologo

Ambulatorio cardiologico

Cardiologo clinico con esperienza scientifica in ambito di:

1) Cardiomiopatie - malattie primitive del miocardio - patologie genetiche - malattie rare in cardiologia - Cardiomiopatia Ipertrofica

2) Cuore d’atleta e valutazioni cardiologiche in giovani atleti

3) Aritmie ventricolari e rischio di morte improvvisa.

4) Malattie del Microcircolo coronarico
5) Prevenzione Cardiovascolare primaria e secondaria.

6) Ipertensione arteriosa

7) rapporto cuore-mente:
- S. di Takotsubo (Cardiomiopatia da Stress)
- Analisi del sistema nervoso autonomo

8) Cardiopatia Ischemia - post-infarto

9) Scompenso cardiaco

9) Valvulopatie

PRESTAZIONI EFFETTUATE:
- Visita cardiologica
- Elettrocardiogramma
- Ecocolordoppler Cardiaco
- Ecocolordoppler Tronchi Sovra-aortici 
- Test da sforzo (opzionale)

Prenotazioni al numero: +393389293792

Mail: davide.lazzeroni@gmail.com

------------------------------------------------------------------
     CURRICULUM STUDIORUM
- 24/10/2006: Laurea in Medicina e Chirurgia con voto 110/110 e lode.
- 02/08/2011: Laurea Specialistica in Cardiologia con voto 50/50 e lode.  
------------------------------------------------------------------

ELENCO PUBBLICAZIONI SCIENTIFICHE

D Lazzeroni, et al. Red Blood Cell Distribution Width: a powerful predictive marker of adverse outcomes after myocardial revascularization or cardiac valve surgery. Nature Scientific Reports 2021 Jan (accepted for publication)

D Lazzeroni,et al. Trabecular complexity as an early marker of cardiac involvement in Fabry disease. Eur Heart J Cardiovasc Imaging. 2021 Jan 22:jeaa354. doi: 10.1093/ehjci/jeaa354. 2020

D Lazzeroni, Concari P, Moderato L. Simultaneous COVID-19 in Monozygotic Twins. Ann Intern Med. 2020 Dec 8:L20-1207. doi: 10.7326/L20-1207. Online ahead of print.

D Lazzeroni, et al. Relationship between aortic stiffness and cardiorespiratory fitness in primary and secondary cardiovascular prevention patients. Eur J Prev Cardiol. 2020

D Lazzeroni, et al. In-hospital day-by-day systolic blood pressure variability during rehabilitation: a marker of adverse outcome in secondary prevention after myocardial revascularization.. Journal of Hypertension 2020

D Lazzeroni, et al.Mitochondrial Energetics and Ca2+-Activated ATPase in Obstructive Hypertrophic Cardiomyopathy. Journal of Clinical Medicine 9 (6), 1799. 2020.

D Lazzeroni, et al. Takotsubo Syndrome During SARS-CoV-2 Pneumonia: A PossibleCardiovascular Complication Giornale italiano di cardiologia. 21 (6), 417-420; 2020.

D Lazzeroni, et al. Cardiopulmonary exercise testing for personalized job reintegration after acute cardiovascular attacks: a pilot cross-sectional study. La Medicina del lavoro 111 (2), 107-115. 2020

D Lazzeroni, et al. Bridging the gap between hypertrabeculation phenotype, noncompaction phenotype and left ventricular noncompaction cardiomyopathy. Journal of Cardiovascular Medicine 2020

D Lazzeroni et al. Delta mapse: an easy-to-use tool to evaluate coronary artery stenosis during dypiridamole pharmacological stress echocardiography. European Heart Journal-Cardiovascular Imaging 21 (Supplement_1), jez319. 976

D Lazzeroni et alPrevention and Rehabilitation European Heart Journal Supplements 21 (Supplement_J), J196-J198. 2019

D Lazzeroni et al. Arterial Hypertension European Heart Journal Supplements 21 (Supplement_J), J32-J34 2019

D Lazzeroni. Health literacy in cardiovascular prevention:‘From small things, big things come’. European journal of preventive cardiology, 2047487319888812. 2019

D Lazzeroni, et al. Septal Late Gadolinium Enhancement and Arrhythmic Risk in Genetic and Acquired Non-ischaemic Cardiomyopathies Heart, Lung and Circulation 2019.

D Lazzeroni, et al. Prognostic role of education levels after cardiac surgery and in hospital cardiac rehabilitation. European Journal of Preventive Cardiology, 20474873198828151. 2019

D Lazzeroni, et al.4951 Long-term prognostic value of adherence to leisure time physical activity prescription in patients undergoing exercise-based cardiac rehabilitation: an inverse dose. European Heart Journal 40 (Supplement_1), ehz746. 0021 2019

D Lazzeroni, et al.P5273 Trabecular complexity as a subclinical structural alteration in Fabry cardiomyopathy: a cardiac magnetic resonance study. European Heart Journal 40 (Supplement_1), ehz746. 0244. 2019

D Lazzeroni, et al. 1177 Insights on mitochondrial energetics inobstructive hypertrophic cardiomyopathy M European Heart Journal 40 (Supplement_1), ehz748. 0019 . 2019

D Lazzeroni, et al. IN HOSPITAL DAY-BY-DAY BLOOD PRESSURE VARIABILITY: A MARKER OF ADVERSE OUTCOME IN SECONDARY CARDIOVASCULAR PREVENTION..Journal of Hypertension 37, e79. 2019 

D Lazzeroni, et al.P620 Mitral annular plane systolic excursion on cardiac magnetic resonance imaging as a predictor of atrial fibrillation in hypertrophic cardiomyopathy. European Heart Journal-Cardiovascular Imaging 20 (Supplement_2), jez116. 023. 2019

D Lazzeroni, et al. 551 Trabecular complexity as a subclinical structural alteration in fabry cardiomyopathy: a cardiac magnetic resonance study. al. European Heart Journal-Cardiovascular Imaging 20 (Supplement_2), jez125. 002. 2019

D Lazzeroni, et al PERCEIVED ANXIETY, EMOTIVE TENSION, COPING STRATEGIES AND AUTONOMIC FUNCTION IN TAKOTSUBO SYNDROME LONG AFTER THE ACUTE PHASE.. EUROPEAN HEART JOURNAL SUPPLEMENTS 21 (E), E66-E66 2019.

D Lazzeroni, et al. PROGNOSTIC ROLE OF EDUCATIONAL ATTAINMENT AFTER EXERCISE-BASED CARDIAC REHABILITATIONEUROPEAN HEART JOURNAL SUPPLEMENTS 21 (E), E66-E68. 2019.

Lazzeroni D, et al.. Serum uric acid level predicts adverse outcomes after myocardial revascularization or cardiac valve surgery.. Eur J Prev Cardiol. 2018 Jan;25(2):119-126. doi: 10.1177/2047487317744045.

Davide Lazzeroni, et al. Prognostic value of frontal QRS-T angle in patients undergoing myocardial revascularization or cardiac valve surgery. Journal of Electrocardiology 51 (2018) 967–972.

Lazzeroni D. Prediction of cardiovascular events using risk scores or electrocardiogram: A farewell to arms. Eur J Prev Cardiol. 2018 Jan;25(1):76-77. doi: 10.1177/2047487317739416.

Lazzeroni D, et al Regarding Article, "Persistent Long-Term Structural, Functional, and Metabolic Changes After Stress-Induced (Takotsubo) Cardiomyopathy"..Circulation. 2018 Aug 28;138(9):960-961. doi: 10.1161/CIRCULATIONAHA.117.033253.

Lazzeroni D, et al. Risk stratification in secondary cardiovascular prevention. Minerva Cardioangiol. 2018 Aug;66(4):471-476. doi: 10.23736/S0026-4725.18.04648-0. Epub 2018


Lazzeroni D, et al. Anxiety disorders and stressful events in Takotsubo syndrome. Cardiol J. 2018;25(4):495-500. doi: 10.5603/CJ.a2017.0136.

D Lazzeroni, et al. P1937 The MyrhythmTM app for automatic detection of atrial fibrillation using commercial chest strap monitors: proof-of-concept accuracy testing in patients undergoing external. European Heart Journal 39 (suppl_1), ehy565. P1937


Lazzeroni D, et al.Multifractal multiscale dfa of cardiovascular time series: Differences in complex dynamics of systolic blood pressure, diastolic blood pressure and heart rate. Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:3477-3480.

Lazzeroni D, et al.Predictive role of P-wave axis abnormalities in secondary cardiovascular prevention. Eur J Prev Cardiol. 2017 Jan 1:2047487317734892. 

D Lazzeroni, et al. SODIUM SENSITIVITY AND INVERSE SODIUM SENSITIVITY IN NORMOTENSIVE AND HYPERTENSIVE INDIVIDUALS..Journal of Hypertension 35, e89. 2017 

D Lazzeroni, et al.P4509 Incremental value of CMR-derived mitral annular plane systolic excursion for atrial fibrillation risk stratification in patients with hypertrophic cardiomyopathy European Heart Journal 38 (suppl_1)2017.

D Lazzeroni, et al.Cardiotoxicity in oncology and coronary microcirculation: future challenges in theranostics. Frontiers in bioscience (Landmark edition) 22 (3/4), 1760-1773 5 2017.

D Lazzeroni, et al. Theranostic biomarkers in hypertrophic cardiomyopathy: insights in a long road ahead.. Frontiers in bioscience (Landmark edition) 22 (1), 1724-1749 1.2017

D Lazzeroni, et al. Calcium channel blockade blunts the renal effects of acute nitric oxide synthase inhibition in healthy humans. American Journal of Physiology-Renal Physiology 312 (5), F870-F878 2 2017

D Lazzeroni, et al.Autonomic function in Takotsubo syndrome long after the acute phase. International journal of cardiology 231, 222-224 10 2017

D Lazzeroni, et al. Improvement in aerobic capacity during cardiac rehabilitation in coronary artery disease patients: is there a role for autonomic adaptations? European journal of preventive cardiology 24 (4), 357-364

D Lazzeroni et al. Prognostic role of stress echocardiography in hypertrophic cardiomyopathy: the International Stress Echo Registry. International journal of cardiology 219, 331-338,18.2016.

D Lazzeroni, et al Hemodynamic and autonomic response to different salt intakes in normotensive individualsP. Journal of the American Heart Association 5 (8), e003736.10.201

Contattaci

Contatti

Chiama ora
  • 338 929 3792

Indirizzo

Indicazioni stradali
Via Goffredo Mameli, 5
43121 Parma PR
Italia
Richiedi preventivo
Messaggio inviato. Ti risponderemo a breve.